Apr 10 |
Moderna (MRNA) Up 6% on Upbeat Data From Cancer Jab Study
|
Apr 9 |
Vincerx (VINC) Tumbles on Results From Cancer Therapy Study
|
Apr 9 |
Is it a Good Idea to Invest in ADMA Biologics (ADMA) Stock Now?
|
Apr 9 |
Palatin (PTN) Up 15% on Results From Dry Eye Disease Study
|
Apr 9 |
Merck (MRK) Begins Phase II/II Ovarian Cancer Study on ADC Drug (Revised)
|
Apr 8 |
Bausch (BHC) Starts Litigation Against Amneal for Xifaxan
|
Apr 8 |
AstraZeneca's (AZN) Enhertu Gets FDA Nod for Solid Tumors
|
Apr 8 |
J&J's (JNJ) $13.1B Shockwave Deal to Boost MedTech Cardio
|
Apr 4 |
Gritstone (GRTS) Plummets 58% in a Week: Here's Why
|
Apr 4 |
Amylyx (AMLX) Withdraws ALS Drug, Cuts Workforce by 70%
|